These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3510588)

  • 1. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa.
    Fine JD; Gay S
    Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa.
    Fine JD; Breathnach SM; Hintner H; Katz SI
    J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.
    Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K
    J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered skin basement membrane antigenicity in epidermolysis bullosa.
    Fine JD
    Curr Probl Dermatol; 1987; 17():111-26. PubMed ID: 3297501
    [No Abstract]   [Full Text] [Related]  

  • 9. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunofluorescence mapping for diagnosis of congenital epidermolysis bullosa].
    Cepeda-Valdés R; Pohla-Gubo G; Borbolla-Escoboza JR; Barboza-Quintana O; Ancer-Rodríguez J; Hintner H; Salas-Alanis JC
    Actas Dermosifiliogr; 2010 Oct; 101(8):673-82. PubMed ID: 20965010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
    Kennedy AR; Heagerty AH; Ortonne JP; Hsi BL; Yeh CJ; Eady RA
    Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa.
    Petronius D; Bergman R; Ben Izhak O; Leiba R; Sprecher E
    Am J Dermatopathol; 2003 Jun; 25(3):198-203. PubMed ID: 12775981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa.
    Fine JD; Holbrook KA; Elias S; Anton-Lamprecht I; Rauskolb R
    Prenat Diagn; 1990 Apr; 10(4):219-29. PubMed ID: 2195497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
    Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA
    Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane.
    Shimizu H; McDonald JN; Gunner DB; Black MM; Bhogal B; Leigh IM; Whitehead PC; Eady RA
    Br J Dermatol; 1990 May; 122(5):577-85. PubMed ID: 2354110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study.
    Schofield OM; Fine JD; Verrando P; Heagerty AH; Ortonne JP; Eady RA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1078-83. PubMed ID: 2273105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin 6-sulfate proteoglycan but not heparan sulfate proteoglycan is abnormally expressed in skin basement membrane from patients with dominant and recessive dystrophic epidermolysis bullosa.
    Fine JD; Couchman JR
    J Invest Dermatol; 1989 Apr; 92(4):611-6. PubMed ID: 2522973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDA-1: a ubiquitous noncollagenous lamina densa component of basement membrane detected by monoclonal antibody technique.
    Fine JD; Gay S
    J Invest Dermatol; 1986 Mar; 86(3):286-9. PubMed ID: 3745953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibodies against the N-terminal noncollagenous domain of type VII collagen encoded by epidermolysis bullosa acquisita antigen cDNA.
    Tanaka T; Matsuyoshi N; Furukawa F; Imamura S
    Dermatology; 1994; 189 Suppl 1():42-5. PubMed ID: 7519486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa.
    Fine JD
    Arch Dermatol; 1990 Sep; 126(9):1187-90. PubMed ID: 2396835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.